| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0065 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |